XML 35 R21.htm IDEA: XBRL DOCUMENT v3.25.1
Comprehensive Income and Equity
 3 Months Ended
Mar. 29, 2025
Equity [Abstract]  
Comprehensive Income and Equity Comprehensive Income and Equity
Comprehensive Income
Comprehensive income is defined as all changes in the Company's net assets except changes resulting from transactions with shareholders. It differs from net income in that certain items recorded in equity are included in comprehensive income.
Accumulated Other Comprehensive Loss
A summary of changes, net of tax, in accumulated other comprehensive loss in the three months ended March 29, 2025, is shown below (in millions):
Three Months Ended March 29, 2025
Defined benefit plans:
Balance at beginning of period$(91.1)
Reclassification adjustments (net of tax benefit of $0.1 million)
(0.3)
Other comprehensive loss recognized during the period(0.1)
Balance at end of period$(91.5)
Derivative instruments and hedging:
Balance at beginning of period$(133.7)
Reclassification adjustments (net of tax expense of $2.7 million)
9.9 
Other comprehensive income recognized during the period (net of tax expense of $17.4 million)
65.2 
Balance at end of period$(58.6)
Foreign currency translation:
Balance at beginning of period$(908.9)
Other comprehensive income recognized during the period (net of tax benefit of $1.3 million)
109.3 
Balance at end of period$(799.6)
Total accumulated other comprehensive loss$(949.7)
In the three months ended March 29, 2025, foreign currency translation adjustments are primarily related to the strengthening of the Euro and, to a lesser extent, the Brazilian real, relative to the U.S. dollar and also include net investment hedge losses of $6.1 million.
A summary of changes, net of tax, in accumulated other comprehensive loss in the three months ended March 30, 2024, is shown below (in millions):
Three Months Ended March 30, 2024
Defined benefit plans:
Balance at beginning of period$(107.3)
Reclassification adjustments(0.3)
Other comprehensive income recognized during the period (net of tax benefit of $0.3 million)
0.4 
Balance at end of period$(107.2)
Derivative instruments and hedging:
Balance at beginning of period$107.9 
Reclassification adjustments (net of tax benefit of $9.3 million)
(34.9)
Other comprehensive income recognized during the period (net of tax expense of $13.1 million)
48.4 
Balance at end of period$121.4 
Foreign currency translation:
Balance at beginning of period$(689.4)
Other comprehensive loss recognized during the period (net of tax expense of $0.6 million)
(79.8)
Balance at end of period$(769.2)
Total accumulated other comprehensive loss$(755.0)
In the three months ended March 30, 2024, foreign currency translation adjustments are primarily related to the weakening of the Euro and, to a lesser extent, the Chinese renminbi, relative to the U.S. dollar and also include pretax losses of $0.1 million
related to intercompany transactions for which settlement is not planned or anticipated in the foreseeable future and net investment hedge gains of $2.9 million.
For further information regarding reclassification adjustments related to the Company's defined benefit plans, see Note 9, "Pension and Other Postretirement Benefit Plans." For further information regarding reclassification adjustments related to the Company's derivative and hedging activities, see Note 17, "Financial Instruments."
Lear Corporation Shareholders' Equity
Common Stock Share Repurchase Program
The Company may implement share repurchases through a variety of methods, including, but not limited to, open market purchases, accelerated stock repurchase programs and structured repurchase transactions. The extent to which the Company may repurchase its outstanding common stock and the timing of such repurchases will depend upon its financial condition, results of operations, capital requirements, prevailing market conditions, alternative uses of capital and other factors.
The Company has a common stock share repurchase program (the "Repurchase Program") which permits the discretionary repurchase of its common stock. Since the inception of the Repurchase Program in the first quarter of 2011, the Company's Board of Directors (the "Board") has authorized $6.7 billion in share repurchases. As of March 29, 2025, the Company has repurchased, in aggregate, $5.6 billion of its outstanding common stock, at an average price of $94.55 per share, excluding commissions and related fees, and has a remaining repurchase authorization of $1.1 billion, which expires on December 31, 2026.
Share repurchases in the first three months of 2025 and the remaining repurchase authorization as of March 29, 2025, are shown below (in millions, except for share and per share amounts):
Three Months Ended March 29, 2025As of March 29, 2025
Aggregate Repurchases (1)
Cash Paid for Repurchases (1)
Number of Shares
Average Price per Share (1)
Remaining Purchase Authorization
$25.0 $25.0 263,003 $95.06 $1,074.9 
(1)     Excludes excise tax and commissions
In addition to shares repurchased under the Repurchase Program described above, the Company classifies shares withheld from the settlement of the Company's restricted stock unit and performance share awards to cover tax withholding requirements as common stock held in treasury in the condensed consolidated balance sheets.
Quarterly Dividend
The Board declared quarterly cash dividends of $0.77 per share of common stock in the first quarters of 2025 and 2024.
Dividends declared and paid are shown below (in millions):
Three Months Ended
March 29,
2025		March 30,
2024
Dividends declared$43.7 $44.9 
Dividends paid43.3 45.5 
Dividends payable on shares of common stock to be distributed under the Company's stock-based compensation program will be paid when such shares are distributed.